NHP vs NBR
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
NHP · National Healthcare Properties$15.24 ▲ 0.20%
NBR · Nabors Industries$73.20 ▲ 2.49%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- NHP +27.6%
- NBR -15.4%
Head to head
| Metric | NHP | NBR |
|---|---|---|
| Price | $15.24 | $73.20 |
| Change today | ▲ 0.20% | ▲ 2.49% |
| Market cap | $1.11B | $1.11B |
| Return, 3 months | -6.8% | -18.5% |
| Return, year to date | – | +34.8% |
| Return, 1 year | – | +42.0% |
| P/E (TTM) | 26.2 | – |
| P/B | 1.2 | 2.0 |
| P/E percentile vs own 5y | 37th | 5th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +2.6% | +6.6% |
| Net profit growth (YoY) | +74.1% | -94.7% |
| Gross margin | 37.9% | 18.6% |
| Operating margin | 9.5% | 7.9% |
| Net margin | -16.7% | -3.0% |
| Return on equity | -6.8% | -17.1% |
| Analyst target vs. price | +26.8% | +43.3% |
| Analyst buy share | 71% | 29% |
| RSI (14) | 48 | 39 |
| 30-day volatility | 37.0% | 57.2% |
| Max drawdown, 1 year | -14.1% | -35.4% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NBR is the largest of the group by market value.
- NBR is growing revenue fastest.
- NBR keeps the most profit per dollar of sales.
- NHP has been the calmest stock over the last 30 days.